Alyeska Investment Group, L.P. Cytokinetics Inc Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Cytokinetics Inc stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 150,000 shares of CYTK stock, worth $6.96 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
150,000
Previous 25,000
500.0%
Holding current value
$6.96 Million
Previous $1.32 Million
434.55%
% of portfolio
0.03%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$681 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$553 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$499 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$366 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$286 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.37B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...